1051

Hope & Healing for Patients with Hepatitis C


Saturday, November 23rd, 2013

Decades after receiving a childhood blood transfusion, Chris Sosinski was shocked to learn he had the hepatitis C virus, which had led to cirrhosis and the prospect of a liver transplant.

Today, Chris remains hepatitis C negative, thanks to a new direct-acting antiviral therapy he received at the UPMC Center for Liver Diseases last year.

Two drugs approved by the Food and Drug Administration (FDA) in 2011 ushered in a new era of treatment, delivering:

  • Improved cure rates
  • Shorter treatment time
  • Better management for the hardest-to-treat strain of the virus

Playing a critical role was the UPMC Center for Liver Diseases, where specialists have been at the forefront in the evaluation and clinical trials of promising new therapies.  “Over the next few years, we expect to have several new options that will eradicate the hepatitis C virus in most patients without side effects,” says Dr. Kapil Chopra, director of the Center for Liver Diseases.

In the tri-state area, UPMC is the leading provider of comprehensive and advanced specialty care for patients with the virus. “Our multidisciplinary specialists are involved in researching and evaluating new treatments. It’s a new era of treatment and hope for our patients,” explains Dr. Chopra.

For more information about these new therapies, visit the UPMC Center for Liver Diseases website or call 412-647-1170.

Center for Liver Diseases

The UPMC Center for Liver Diseases is a comprehensive care center focusing on the management and treatment of a variety of liver diseases. Whether you are being seen for complications of chronic liver disease/cirrhosis of the liver, surgical evaluation of hepatobiliary disorders, evaluation for liver transplantation, or enrollment in a clinical trial, our multidisciplinary, integrated approach to diagnosing and treating liver disorders provides patients with high quality care in a timely and convenient manner. Read More